GTBPVSSLXN• 28 Days (Normalized)
GTBP vs SLXN (GT Biopharma Inc. vs Silexion Therapeutics Corp)
Showing Closing Date Range from Aug 31 to Sep 28, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $7.1
+2382.52%
GT Biopharma Inc.
Normalized Baseline0.00%
SLXN Performance $0.32
-14.86%
Silexion Therapeutics Corp
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+2397.38 pts
GTBP outperforming by 2397.38 percentage points
GTBPSLXN
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP SLXN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(17 dates)
| Date | GTBP Price | GTBP Gain (%) | SLXN Price | SLXN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $7.10 | +2382.52% | $0.32 | -14.86% | +2397.38% |
| Sep 22, 2026 | $- | $0.39 | +5.95% | - | |
| Sep 21, 2026 | $7.18 | +2410.49% | $0.54 | +47.03% | +2363.46% |
| Sep 18, 2026 | $7.16 | +2403.50% | $0.44 | +17.84% | +2385.66% |
| Sep 17, 2026 | $7.49 | +2518.88% | $0.38 | +2.70% | +2516.18% |
| Sep 16, 2026 | $7.81 | +2630.77% | $0.34 | -8.11% | +2638.88% |
| Sep 15, 2026 | $9.00 | +3046.85% | $0.34 | -8.11% | +3054.96% |
| Sep 14, 2026 | $11.63 | +3966.43% | $0.39 | +4.16% | +3962.27% |
| Sep 11, 2026 | $8.61 | +2910.49% | $0.36 | -3.51% | +2914.00% |
| Sep 10, 2026 | $6.18 | +2060.84% | $0.42 | +14.32% | +2046.52% |
| Sep 09, 2026 | $5.98 | +1990.91% | $0.35 | -5.41% | +1996.32% |
| Sep 08, 2026 | $- | $0.35 | -6.76% | - | |
| Sep 04, 2026 | $0.24 | -15.73% | $0.35 | -4.86% | -10.87% |
| Sep 03, 2026 | $0.25 | -11.89% | $0.35 | -4.86% | -7.03% |
| Sep 02, 2026 | $0.28 | -1.05% | $0.35 | -5.14% | +4.09% |
Page 1 of 2